Parametric model of combination therapy for Non-Hodgkin Lymphoma.

Parametric model of combination therapy for Non-Hodgkin Lymphoma.

The development and clinical testing of drug combinations for the treatment of Non-Hodgkin Lymphoma (NHL) and other cancers has recently shown great promise. However, determining the optimum combination and its associated dosages for maximum efficacy and minimum side effects is still a challenge. Th...

Full description

Bibliographic Details
Main Authors: Robert F Weiss, Merlin G Miller, John F Cronin, Harvey H Hensley, Indira D Joshi, Mitchell R Smith
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3522695?pdf=render

Internet

http://europepmc.org/articles/PMC3522695?pdf=render

Similar Items